QNTM Quantum BioPharma Ltd.

P/E --
Forward P/E --
Price/Sales 91.86
Beta 0.362
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Quantum BioPharma is trading 5.3% up today; no clear catalyst identified

Quantum BioPharma is trading 5.32% higher at $2.97, with no clear company-specific catalyst identified for the October 13 move. - A summit announcement...

🟒 Quantum BioPharma is trading 5.7% up in after-hours trading; catalyst remains unclear

Quantum BioPharma is trading at $2.98, up 5.67%, after its October 12 after-hours rise, for which no clear company-specific catalyst was identified. - The...

πŸ”΄ Quantum BioPharma is trading 5% down with no clear catalyst identified

Quantum BioPharma is trading at $2.95, down 5.14%, with no direct catalyst established in available reporting. - No clear company-specific announcement on...

πŸ”΄ Quantum BioPharma is trading 8.4% down in pre-market

Quantum BioPharma is trading at $2.83, down 8.40%, in pre-market, with no clearly identified overnight catalyst for the October 7 decline. - On October 6, the...

🟒 Quantum BioPharma is trading 5% up in after-hours trading

Quantum BioPharma is trading at $3.25, up 5.17% after hours, with no clear catalyst identified. - The move compares with the October 6 regular-session close...

πŸ”΄ Quantum BioPharma is trading 5.5% down today with biotech weakness a possible factor

Quantum BioPharma is trading 5.5% down at $3.09, with biotech-sector weakness a possible contributing factor. - On October 6, the company announced a Thermo...

🟒 Quantum BioPharma is trading 13% up in pre-market; no specific catalyst verified

Quantum BioPharma is trading at $3.69, up 12.84% in pre-market; no specific catalyst has been verified. - The October 5 close was $3.27; recent closes had...

🟒 Quantum BioPharma is trading 7.7% up in pre-market with no new catalyst identified

Quantum BioPharma is up 7.7% in pre-market at $3.52, versus $3.27 at the October 5 close; the reason is unclear. - No October 6 company announcement surfaced;...

🟒 Quantum BioPharma is trading 7.5% up in pre-market with no confirmed catalyst

Quantum BioPharma is trading 7.45% up at $3.68 in pre-market on October 2, with no confirmed company-specific catalyst. - Shares rebounded from the October 1...

πŸ”΄ Quantum BioPharma is trading 5% down

Quantum BioPharma is trading at $3.42, down 5.00%, with no clear company-specific catalyst identified for October 1, 2026. - Available coverage showed no...

πŸ”΄ Quantum BioPharma is trading 7% down today with no clear catalyst identified

Quantum BioPharma is trading at $3.57, down 6.65%, with no clear company-specific catalyst for the September 30, 2026 decline found in available coverage. - A...

πŸ”΄ Quantum BioPharma is trading 5% down today

Quantum BioPharma is trading 5.2% down at $3.75, with no new company-specific announcement identified to explain the September 29 move. - FDA IND clearance for...

🟒 Quantum BioPharma is trading 5% up in pre-market with no confirmed catalyst

Quantum BioPharma is trading up 5.41% in pre-market at $4.06 on September 28; no new company announcement dated September 28 surfaced in the search. - The...

Quantum BioPharma Jumps 11% on a New CEO Hire β€” But Can a Licensing Bet Deliver Real Revenue for a $30 Million Company?

Shares of Quantum BioPharma (NASDAQ: QNTM) surged +10.8% to $4.30 on September 24, defying a weak biotech tape, after its licensee Unbuzzd Wellness named...

🟒 Quantum BioPharma is trading 10.8% up today after licensee Unbuzzd Wellness appointed Michael Zapolin CEO

Quantum BioPharma is trading at $4.30, up 10.82%, with Unbuzzd Wellness’s CEO appointment appearing to be the clearest company-specific catalyst. - The...

🟒 Quantum BioPharma is trading 5.7% up today amid reported premarket sector strength

Quantum BioPharma is trading 5.71% higher at $4.10, with sector-related strength reported in premarket trading. - A September 24 announcement said licensee...

🟒 Quantum BioPharma is trading 5% up in pre-market as biotech ETF XBI gains

Quantum BioPharma is trading 5.15% higher at $4.08, with the move appearing primarily sector-driven as biotech ETF XBI rises pre-market. - Shares are up from...

🟒 Quantum BioPharma is trading 13.5% up today β€” catalyst unconfirmed

Quantum BioPharma is trading 13.5% higher at $4.20, with no specific catalyst confirmed. - No new company-specific announcement was identified on September...

🟒 Quantum BioPharma is trading 5% up today amid a 2.07% biotech-sector rise

Quantum BioPharma is trading at $3.90, up 5.27%, with the move appearing primarily sector-driven as biotechnology rose 2.07%. - No new company-specific...

🟒 Quantum BioPharma is trading 5% up today amid 2.07% biotechnology gains

Quantum BioPharma is trading 5.26% up at $3.80, primarily amid biotechnology-sector momentum; no new company-specific announcement was identified for September...